Among the small molecules that have been shown to inhibit the HIPK2 kinase activity [36] and that can be administered in vivo, we selected the 5-ITu because it has been shown to promote the replacement of islet β-cells from rodent, porcine, and human upon transplantation into immunocompromised mice for diabetes treatment [23]. Here, HIPK2 is linked to diabetes mellitus.